EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?

Hassan Melhem, Jan Hendrik Niess iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158534 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hassan Melhem und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Group, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic esophagitis (EoE) and inflammatory bowel disease (IBD) are chronic inflammatory disorders of the gastrointestinal tract, with EoE predominantly provoked by food and aeroallergens, whereas IBD is driven by a broader spectrum of immunopathological and environmental triggers. This review presents a comprehensive comparison of the pathophysiological and therapeutic strategies for EoE and IBD. We examine the current understanding of their underlying mechanisms, particularly the interplay between environmental factors and genetic susceptibility. A crucial element in both diseases is the integrity of the epithelial barrier, whose disruption plays a central role in their pathogenesis. The involvement of eosinophils, mast cells, B cells, T cells, dendritic cells, macrophages, and their associated cytokines is examined, highlighting the importance of targeting cytokine signaling pathways to modulate immune–epithelial interactions. We propose that advances in computation tools will uncover the significance of G-protein coupled receptors (GPCRs) in connecting immune and epithelial cells, leading to novel therapies for EoE and IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisInflammatory Bowel DiseasesHumansAnimalsCytokinesEosinophilsGenetic Predisposition to Disease

Stichwörter der Autor:innen

eosinophilic esophagitisepithelial barrier disruptionimmune-mediated epithelial damageimmune–epithelial crosstalkinflammatory bowel diseasemucosal barrier integrity

Substanzen

Cytokines

Autor:innen und Institutionen

  • Gastroenterology Group, Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.
  • Department of Gastroenterology and Hepatology, University Digestive Healthcare Center, Clarunis, 4002 Basel, Switzerland.

ORCID-Profile: Jan Hendrik Niess

Förderung

  • Swiss National Science Foundation

Zitieren

APA

Melhem, H., & Niess, J. H. (2024). Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158534

Vancouver

Melhem H, Niess JH. Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158534

BibTeX
@article{Melhem2024,
  author = {Melhem, Hassan and Niess, Jan Hendrik},
  title = {Eosinophilic Esophagitis and Inflammatory Bowel Disease: What Are the Differences?},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158534}
}
Kostenlos starten →